Trial · NCT07911475
Evaluation of the Effects of Virtual Reality Applications on Salivary Cortisol Levels and Vital Signs in Adults With Dental Anxiety During Restorative Dental Treatments
NCT07911475, Completed, Dokuz Eylul University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evaluation of the Effects of Virtual Reality Applications on Salivary Cortisol Levels and Vital Signs in Adults With Dental Anxiety During Restorative Dental Treatments. Trials, record NCT07911475. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07911475
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evaluation of the Effects of Virtual Reality Applications on Salivary Cortisol Levels and Vital Signs in Adults With Dental Anxiety During Restorative Dental Treatments
- NCT number
- NCT07911475
- Status
- Completed
- Enrollment
- 250 participants, actual
- Lead sponsor
- Dokuz Eylul University
- Conditions
- Dental Anxiety, Music Therapy, Salivary Cortisol, Virtual Reality (VR) Technology
- Interventions
- Music Therapy
- First posted
- 2026-11-02
- Last updated
- 2026-11-02
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Salivary Cortisol Level | Baseline (immediately before restorative dental treatment) and immediately after completion of the dental procedure (Day 1) | Salivary cortisol concentration was measured in micrograms per deciliter (µg/dL) using saliva samples collected before and after restorative dental treatment. Changes in salivary cortisol levels were calculated as the post-treatment value minus the baseline value to evaluate the physiological stress response associated with virtual reality exposure during dental treatment. |
| Primary | Change in Heart Rate | Baseline (immediately before restorative dental treatment) and immediately after completion of the dental procedure (Day 1) | Heart rate was measured in beats per minute (bpm) using a digital pulse oximeter before and after restorative dental treatment. Changes in heart rate were calculated as the post-treatment value minus the baseline value to evaluate physiological responses to virtual reality exposure during the procedure. |
| Primary | Change in Systolic Blood Pressure | Baseline (immediately before restorative dental treatment) and immediately after completion of the dental procedure (Day 1) | Systolic blood pressure was measured in millimeters of mercury (mmHg) using a digital blood pressure monitor before and after restorative dental treatment. Changes in systolic blood pressure were calculated as the post-treatment value minus the baseline value to evaluate physiological responses to virtual reality exposure during the procedure. |
| Primary | Change in Diastolic Blood Pressure | Baseline (immediately before restorative dental treatment) and immediately after completion of the dental procedure (Day 1) | Diastolic blood pressure was measured in millimeters of mercury (mmHg) using a digital blood pressure monitor before and after restorative dental treatment. Changes in diastolic blood pressure were calculated as the post-treatment value minus the baseline value to evaluate physiological responses to virtual reality exposure during the procedure. |
| Primary | Change in Body Temperature | Baseline (immediately before restorative dental treatment) and immediately after completion of the dental procedure (Day 1) | Body temperature was measured in degrees Celsius (°C) using a digital thermometer before and after restorative dental treatment. Changes in body temperature were calculated as the post-treatment value minus the baseline value to evaluate physiological responses to virtual reality exposure during the procedure. |
| Primary | Change in Peripheral Oxygen Saturation (SpO₂) | Baseline (immediately before restorative dental treatment) and immediately after completion of the dental procedure (Day 1) | Peripheral oxygen saturation (SpO₂) was measured as a percentage (%) using a digital pulse oximeter before and after restorative dental treatment. Changes in oxygen saturation were calculated as the post-treatment value minus the baseline value and expressed in percentage points to evaluate physiological responses to virtual reality exposure during the procedure. |
| Primary | Baseline Dental Anxiety Level | Baseline (before restorative dental treatment, Day 1). | Baseline dental anxiety was assessed using the Modified Dental Anxiety Scale (MDAS), a five-item questionnaire with a total score ranging from 5 to 25. Higher scores indicate greater dental anxiety. The scale was administered before restorative dental treatment to determine participants' baseline dental anxiety levels. |
| Secondary | Patient Satisfaction Following Restorative Dental Treatment | Immediately after completion of restorative dental treatment (Day 1). | Patient satisfaction with the restorative dental treatment experience was assessed immediately after the procedure using a five-point Likert-type satisfaction scale. Higher scores indicate greater patient satisfaction. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07911475
GET https://conductscience.org/api/trials/v1/NCT07911475/registered